MedPath

Impact of a Non-Drug Choice on Cocaine Reinforcement

Early Phase 1
Completed
Conditions
Cocaine Dependence
Interventions
Drug: Placebo
Registration Number
NCT01906346
Lead Sponsor
Joshua A. Lile, Ph.D.
Brief Summary

Cocaine-use disorders continue to be a significant public health concern, yet no effective medications have been identified. The goal of this study is to establish a research platform for the development of medications for treatment of cocaine abuse and dependence. This study will incorporate self-administration procedures and a non-drug alternative reinforcer, which is hypothesized to reduce the reinforcing effects of cocaine.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
9
Inclusion Criteria
  • Cocaine dependence, otherwise healthy
Exclusion Criteria
  • Laboratory results outside of clinically acceptable ranges, history of or current serious physical or psychiatric disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Low Value Alternative ReinforcerPlaceboA low value reinforcer will be made available as an alternative to cocaine and placebo.
High Value ReinforcerPlaceboA high value reinforcer will be made available as an alternative to cocaine and placebo.
Medium Value ReinforcerCocaineA medium value reinforcer will be made available as an alternative to cocaine and placebo.
Medium Value ReinforcerPlaceboA medium value reinforcer will be made available as an alternative to cocaine and placebo.
Low Value Alternative ReinforcerCocaineA low value reinforcer will be made available as an alternative to cocaine and placebo.
High Value ReinforcerCocaineA high value reinforcer will be made available as an alternative to cocaine and placebo.
Primary Outcome Measures
NameTimeMethod
The Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative9 choice trials per cocaine dose level with each trial separated by 30 minutes

The reinforcing effects of cocaine were determined using a modified progressive ratio procedure in which subjects made 9 choices between each available cocaine dose and one of three money alternatives.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Laboratory of Human Behavioral Pharmacology

🇺🇸

Lexington, Kentucky, United States

© Copyright 2025. All Rights Reserved by MedPath